(Q74575003)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12162191%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

review article

1 reference

title

[Angiogenesis and bladder cancer: trendy prognostic factor or new therapeutic target?] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12162191%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

1 reference

C Jayet

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12162191%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

D Deperthes

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12162191%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

H J Leisinger

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12162191%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 July 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12162191%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12162191%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12162191%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12162191%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

258-263

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12162191%20AND%20SRC:MED&resulttype=core&format=json

Tumor dormancy in vivo by prevention of neovascularization

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900105-5

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900105-5

Relation of neovascularisation to metastasis of non-small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900105-5

Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900105-5

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900105-5

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900105-5

Macrophage-derived angiogenesis factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900105-5

Angiogenic Activity as a Marker of Neoplastic and Preneoplastic Lesions of the Human Bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900105-5

Detection of Angiogenesis Activity in Malignant Bladder Tissue and Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900105-5

Urine from patients with transitional-cell carcinoma stimulates migration of capillary endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900105-5

Fluorescein angiography of the bladder: technique and relevance to bladder cancer and interstitial cystitis patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900105-5

Antitumour effects of the angiogenesis inhibitor AGM-1470 on rat urinary bladder tumours induced by N-butyl-N-(4-hydroxybutyl) nitrosamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900105-5

Quantification of angiongenesis as an independent predictor of prognosis in invasive bladder carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900105-5

Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900105-5

Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900105-5

Prognostic significance of angiogenesis in transitional cell carcinoma of the human urinary bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900105-5

Prognostic significance of angiogenesis and immunoreactivity of cathepsin D and type IV collagen in high-grade stage T1 primary bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900105-5

Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900105-5

Increased immunodetection of acidic fibroblast growth factor in bladder cancer, detectable in urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900105-5

Inhibition of angiogenesis by thrombospondin-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900105-5

A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900105-5

Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900105-5

Intravesical bacille Calmette-Guérin induces the antiangiogenic chemokine interferon-inducible protein 10.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900105-5

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900105-5

Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900105-5

Angiostatin induces and sustains dormancy of human primary tumors in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900105-5

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900105-5

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900105-5

Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900105-5

Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900105-5

Combined effects of angiostatin and ionizing radiation in antitumour therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900105-5

Are angiostatin and endostatin cures for cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900105-5

Angiogenesis antagonists: current clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900105-5

Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900105-5

Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900105-5

How tumors become angiogenic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900105-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0003-4401(02)00105-5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12162191%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference